 | Up a level |
Cappellini, M.D. and Elalfy, M. and El-Beshlawy, A. and Kattamis, A. and Chan, L.L. and Li, C. and Lin, K.H. and Quarta, G. and Sutcharitchan, P. and Taher, A. and Habr, D. and Roubert, B. and Porter, J. (2010) Efficacy of deferasirox in patients with thalassaemia major is not affected by a history of hepatitis B OR C. Haematologica-The Hematology Journal, 95 (2). pp. 718-719.
Cappellini, M.D. and Porter, J. and El-Beshlawy, A. and Li, C.K. and Seymour, J.F. and Elalfy, M. and Gattermann, N. and Giraudier, S. and Lee, J.W. and Chan, L.L. and Lin, K.H. and Rose, C. and Taher, A. and Thein, S.L. and Viprakasit, V. and Habr, D. and Domokos, G. and Roubert, B. and Kattamis, A. and Investigators, EPIC Study (2010) Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias. Haematologica-The Hematology Journal, 95 (4). pp. 557-566.
